BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,657,354 | +45.4% | 254,578 | +44.5% | 0.13% | +47.7% |
| Q2 2023 | $19,017,266 | +10.9% | 176,200 | +28.0% | 0.09% | +3.6% |
| Q1 2023 | $17,153,289 | -69.7% | 137,700 | -63.5% | 0.08% | -74.6% |
| Q4 2022 | $56,613,862 | +11.9% | 376,873 | +0.5% | 0.33% | +55.0% |
| Q3 2022 | $50,581,000 | -33.4% | 375,006 | -32.8% | 0.21% | +45.5% |
| Q2 2022 | $75,980,266 | -19.0% | 558,249 | +1.5% | 0.14% | -27.5% |
| Q1 2022 | $93,827,000 | -46.2% | 550,107 | -18.8% | 0.20% | -46.2% |
| Q4 2021 | $174,550,000 | -17.4% | 677,079 | -12.5% | 0.37% | -21.2% |
| Q3 2021 | $211,330,000 | +758.3% | 774,130 | +603.9% | 0.47% | +713.8% |
| Q2 2021 | $24,623,000 | +518.4% | 109,981 | +201.6% | 0.06% | +480.0% |
| Q1 2021 | $3,982,000 | – | 36,469 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |